
    
      IVIG at an immunomodulatory dose of 1 g/Kg body weight has been known to induce suppression
      of systemic inflammation and has been used in the treatment of autoimmune diseases. It has
      been proven beneficial in inflammatory conditions affecting the nervous system.
    
  